ACORDA THERAPEUTICS INC 4
4 · ACORDA THERAPEUTICS INC · Filed Nov 23, 2015
Insider Transaction Report
Form 4
Blight Andrew
Chief Scientifc Officer
Transactions
- Sale
Common Stock
2015-11-20$37.47/sh−500$18,735→ 71,659 total - Exercise/Conversion
Common Stock
2015-11-20$8.50/sh+500$4,250→ 72,159 total - Exercise/Conversion
Employee Stock Option (right to buy)
2015-11-20−500→ 0 totalExercise: $8.50Exp: 2016-09-25→ Common Stock (500 underlying)
Footnotes (2)
- [F1]Exercises and sales pursuant to a 10b5-1 Plan. The exercised options were scheduled to expire in 2016 on the expiration date reported within Table II unless exercised.
- [F2]The shares subject to these options vested in installments and were fully vested on 9/25/2010.